Nowoczesne metody diagnostyki genetycznej
1655-Lek3DIGE-J
The lecture is aimed at acquiring and systematizing knowledge of newly introduced genetic and epigenetic biomarkers assessed by methods such as qPCR, MLPA, capillary sequencing or high-throughput technologies. Discussion of the liquid biopsy and the possibility of examining circulating tumor cells, free, extracellular DNA, miRNA. Discussion of the usefulness of circulating cancer DNA testing in patient monitoring; Discussion of usefulness of panels/molecular profiles. Seminars are devoted to familiarizing with modern techniques, mainly in the field of molecular genetics (but also in the field of molecular cytogenetics). Discussing interpretation difficulties; Case analysis and interpretation of genetic results will be performed using innovative technologies for constitutive and somatic changes
Całkowity nakład pracy studenta
1. The workload related to the classes requiring the direct participation of academic teachers is:
- participation in lectures: 4 hours
- participation in seminars: 6 hours
- participation in exercises: 0.5 hours
- consultation: 0.5 hour
- completion of the test: 0.5 hour
The workload related to the activities requiring the direct participation of academic teachers amounts to
11 hours, corresponding to 0.44 ECTS points
2. Balance of student workload:
- participation in lectures: 4 hours
- participation in seminars: 6 hours
- consultation: 0.5 hour
- preparation for the seminar (including reading the indicated literature): 9.5 hours
- preparation for exercises (including reading the indicated literature): 12 hours
- preparation for passing and passing: 9 + 0.5 = 9.5 hours
The total student workload is 13.5 hours, which corresponds to 0.54 ECTS points
3. Workload related to the conducted research: Not applicable
4. Time required to prepare for and participate in the assessment process:
- preparation for the test: 9 + 0.5 = 9.5 hours (0.38 ECTS points)
5. Balance of student workload of a practical nature:
- participation in seminars: 6 hours
- preparation for the seminar (including reading the indicated literature): 6 hours; 0.24 ECTS
The total student workload of a practical nature is
6 hours, corresponding to 0.24 ECTS points
6. Time required for compulsory internship: not applicable
Efekty uczenia się - wiedza
Student:
W1: Characterizes new genetic and epigenetic biomarkers in oncology, introduced for diagnosis or clinical trials; qPCR methods, MLPA capillary sequencing (C.W7, C.W9, C.W.41, E.W.24, E.W.39). W2. Characterizes liquid biopsy and genetic biomarkers for therapy monitoring (circulating tumor cells, circulating DNA, exosomes, miRNAs (C.W11, C.W9, C.W.41, C.W.42, E.W.25, E.W.39). W3. Discusses high-throughput diagnostic methods as tools for detecting constitutive and somatic changes (microarrays, next-generation sequencing, including WES) (C.W9, C.W11, C.W.24, C.W.41, C.W.42, E.W.39); W.4 Discusses international standards for interpreting next-generation sequencing results (C.W.41, E.W.37); automation of diagnostic processes and the use of panels/molecular profiles
Efekty uczenia się - umiejętności
Student:
U1. Correctly distinguishes examinations in the detection of somatic versus constitutive changes; He can evaluate the value of tests using new technologies such as qPCR, NGS, microarrays, MLPA in the diagnostic process. knows how to plan the collection of appropriate material for research, including material for monitoring genetic changes related to the acquisition of drug resistance by cancer cells (E.U16, E.U24, E,U28). U2. Can decide on the need to perform tests to monitor therapy using new technologies (E.U16) U3. knows international standards for interpreting next-generation sequencing results, understands the concepts of VUS; pathogenic lesion, possibly pathogenic lesion, likely benign lesion, and benign lesion (stage I-V, scale I-IV);
Efekty uczenia się - kompetencje społeczne
Student:
K_K06. implementing the principles of professional camaraderie and cooperation in a team of specialists, including representatives of other medical professions, also in a multicultural and multinational environment K_K07. noticing and recognizing one's own limitations and self-assessing deficits and educational needs in the field of genetic research and updating interpretations, the importance of innovative molecular biology techniques in oncological genetics
Metody dydaktyczne
Lectures: • informative lecture with the possibility of discussion Seminars: • seminars and multimedia presentations• assisted learning with a multimedia presentation
• method of didactic discussion
• case studies
Tutorials:
• instructional demonstration
• subject exercises
• simulation methods (case study; simulated patient)
Metody dydaktyczne podające
- wykład problemowy
- wykład konwersatoryjny
Metody dydaktyczne poszukujące
- seminaryjna
- studium przypadku
Wymagania wstępne
A student commencing education in the field of Modern Methods of Genetic Diagnostics should have knowledge of the basics of medical genetics and molecular biology
Koordynatorzy przedmiotu
Kryteria oceniania
LECTURES The course credit consists of an oral answer (1-3 points); covers issues discussed in lectures and seminars. The condition for passing is to obtain 56% of points from the oral answer.
SEMINARS: Completion of the seminars is a condition for admission to the subject. During the seminars, students can prepare a poster in the subassemblies, draw a diagram or prepare a multimedia presentation on a selected innovative technology; the above activity during seminars - may be rewarded with additional privileges, e.g. passing the course (without the final oral answer
Praktyki zawodowe
Literatura
Primary: literature
“Abeloff's Clinical Oncology, 6th Edition; Authors : John E. Niederhuber & James O. Armitage & James H Doroshow & Michael B. Kastan & Joel E. 2019
Prognostic and predictive biomarkers: tools in personalized oncology.”Nalejska E, Mączyńska E, Lewandowska MA. Mol Diagn Ther. 2014”
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group Annals of Oncology Volume 31, Issue 11, November 2020, Pages 1491-1505
Uwagi
Więcej informacji
Dodatkowe informacje (np. o kalendarzu rejestracji, prowadzących zajęcia, lokalizacji i
terminach zajęć) mogą być dostępne w serwisie USOSweb: